Market Place
Sourcing Support
CB Therapeutics Innovates Sustainable Medicine Production
15 Jan 2025 //
ACCESSWIRE
CB Therapeutics granted a new patent for psychedelic research
19 May 2022 //
GLOBENEWSWIRE
CB Therapeutics rapidly expands cellular agriculture capabilities
25 Apr 2022 //
GLOBENEWSWIRE
Two esteemed doctors join CB Therapeutics in its exploration of approaches
20 Dec 2021 //
GLOBENEWSWIRE
CB Therapeutics and atai Life Sciences launch TryptageniX
09 Dec 2021 //
GLOBENEWSWIRE
CB Therapeutics Expands Biomanufacturing IP Portfolio
24 Aug 2021 //
BUSINESSWIRE
CB Therapeutics Closes on Oversubscribed Series A
10 May 2021 //
BUSINESSWIRE
CB Therapeutics in-house Downstream Processing & Purification, Low-cost
23 Sep 2020 //
BUSINESSWIRE
CB Therapeutics Achieves Another Breakthrough with the Biosynthesis of DMT
03 Jun 2020 //
BUSINESSWIRE
CB Therapeutics Achieves Another Breakthrough with the Biosynthesis of DMT
03 Jun 2020 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.